The biotech index looks sad so far. However, considering a specific stock, we have that we have bullish divergences, although not sure, the level, as well as the ema200 for the week.
From the fundamental one, you can attract interest in RNAi technology. Recently, DRNA was purchased with their platform, this company has its own, respectively, and the same areas of research.
From the fundamental one, you can attract interest in RNAi technology. Recently, DRNA was purchased with their platform, this company has its own, respectively, and the same areas of research.
Clause de non-responsabilité
Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.